Rosalyn W Stewart
Overview
Explore the profile of Rosalyn W Stewart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Galiatsatos P, Hailey-Fair K, Johnson M, Vanderpool E, Stewart R, Alexander K, et al.
Front Public Health
. 2024 Dec;
12:1480795.
PMID: 39678242
The arts and aesthetic experiences have fostered and enhanced relationships between diverse, distinct groups in an effort to build comradery, trust, and engagement. In regards to collaborations between health systems...
2.
Meilhac M, Nesbit S, Bowman L, Stewart R
South Med J
. 2024 Jul;
117(7):371-373.
PMID: 38959965
No abstract available.
3.
DAmiano N, Bertram A, Matthew Stewart C, Stewart R
Otolaryngol Head Neck Surg
. 2024 Jun;
171(5):1394-1400.
PMID: 38881410
Objective: To assess the association between provider type (primary care provider [PCP] or perioperative provider) and excessive preoperative testing. Study Design: Cross-sectional study. Setting: Academic medical center. Methods: Electronic medical...
4.
Kuye I, Prichett L, Stewart R, Berkowitz S, Buresh M
J Hosp Med
. 2024 Mar;
19(5):377-385.
PMID: 38458154
Background: Prior single-hospital studies have documented barriers to acceptance that hospitalized patients with opioid use disorder (OUD) face when referred to skilled nursing facilities (SNFs). Objective: To examine the impact...
5.
Bodnar A, Diffenderffer C, Jablonski L, Bai E, Stewart R
J Addict Dis
. 2023 Dec;
42(4):567-571.
PMID: 38044861
Introduction: Buprenorphine is used to treat opioid use disorder (OUD). However, therapy is often disrupted during acute pain episodes, and re-initiation is often deferred due to intolerable interruption in opioid...
6.
Borris J, Dowd-Green C, Bowman L, Nesbit S, Fingerhood M, Stewart R
J Subst Use Addict Treat
. 2023 Nov;
156:209209.
PMID: 37939905
Introduction: In clinical practice, sublingual (SL) buprenorphine-naloxone is prescribed as once daily or split daily dosing for the management of opioid use disorder (OUD). Evidence is lacking that assesses how...
7.
Linton E, Williams E, Early M, Prince E, Stewart R, Lanzkron S, et al.
EJHaem
. 2023 Aug;
4(3):587-594.
PMID: 37601884
Sexual and reproductive healthcare standards for adolescents and young adults with sickle cell disease (SCD) are not established. A total of 50 young adults entering adult SCD care completed a...
8.
Garibaldi B, Chisolm M, Berkenblit G, Feller-Kopman D, Stephens R, Stewart R, et al.
Postgrad Med J
. 2023 Apr;
98(1165):880-886.
PMID: 37063034
COVID-19 continues to be a major source of global morbidity and mortality. It abruptly stressed healthcare systems early in 2020 and the pressures continue. Devastating hardships have been endured by...
9.
Rasmussen P, Bertram A, Dowd-Green C, Stewart R
J Correct Health Care
. 2022 Jul;
28(4):227-229.
PMID: 35793517
People released from prison are at risk of adverse health outcomes in the weeks after release. This article describes cases that illustrate the complexity of caring for this population. It...
10.
Jablonski L, Bodnar A, Stewart R
Drug Alcohol Depend
. 2022 Jun;
237:109541.
PMID: 35753281
Background: Buprenorphine is a life-saving treatment for opioid use disorder (OUD). Low-dose initiation (LDI) is an emerging buprenorphine initiation strategy that circumvents barriers associated with standard initiation. This study aims...